Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117155) titled 'non-pCR adaptive immune therapy(CTONG 2508-ADAPT-Lung)' on Jan. 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Chengdu Third People's Hospital
Condition:
NSCLC
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-02-07
Target Sample Size: Test group:115;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=304549
Disclaimer: Curated by HT Syndication....